297 related articles for article (PubMed ID: 12084849)
21. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
22. Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
Hoppel CL
Fed Proc; 1982 Oct; 41(12):2853-7. PubMed ID: 7128831
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium.
Tyni T; Johnson M; Eaton S; Pourfarzam M; Andrews R; Turnbull DM
Pediatr Res; 2002 Oct; 52(4):595-600. PubMed ID: 12357056
[TBL] [Abstract][Full Text] [Related]
24. Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid beta-oxidation defects: phenotype/metabolite correlations.
Giak Sim K; Carpenter K; Hammond J; Christodoulou J; Wilcken B
Mol Genet Metab; 2002 Aug; 76(4):327-34. PubMed ID: 12208138
[TBL] [Abstract][Full Text] [Related]
25. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
26. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
Purevsuren J; Kobayashi H; Hasegawa Y; Yamada K; Takahashi T; Takayanagi M; Fukao T; Fukuda S; Yamaguchi S
Anal Bioanal Chem; 2013 Feb; 405(4):1345-51. PubMed ID: 23143007
[TBL] [Abstract][Full Text] [Related]
27. Impaired mitochondrial fatty acid oxidative flux in fibroblasts from a patient with malonyl-CoA decarboxylase deficiency.
Bennett MJ; Harthcock PA; Boriack RL; Cohen JC
Mol Genet Metab; 2001 Jul; 73(3):276-9. PubMed ID: 11461195
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
[TBL] [Abstract][Full Text] [Related]
29. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.
Dessein AF; Fontaine M; Dobbelaere D; Mention-Mulliez K; Martin-Ponthieu A; Briand G; Vamecq J
Clin Chim Acta; 2009 Aug; 406(1-2):23-6. PubMed ID: 19422814
[TBL] [Abstract][Full Text] [Related]
30. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
31. Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate.
Djouadi F; Bonnefont JP; Thuillier L; Droin V; Khadom N; Munnich A; Bastin J
Pediatr Res; 2003 Oct; 54(4):446-51. PubMed ID: 12840153
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
33. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
[TBL] [Abstract][Full Text] [Related]
34. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
[TBL] [Abstract][Full Text] [Related]
35. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.
Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis of mitochondrial fatty acid oxidation defects.
Nada MA; Vianey-Saban C; Roe CR; Ding JH; Mathieu M; Wappner RS; Bialer MG; McGlynn JA; Mandon G
Prenat Diagn; 1996 Feb; 16(2):117-24. PubMed ID: 8650121
[TBL] [Abstract][Full Text] [Related]
37. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
[TBL] [Abstract][Full Text] [Related]
38. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
39. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a short-chain carnitine-acylcarnitine translocase in mitochondria specifically related to the metabolism of branched-chain amino acids.
Roe DS; Roe CR; Brivet M; Sweetman L
Mol Genet Metab; 2000 Jan; 69(1):69-75. PubMed ID: 10655160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
